An epidemiological study to evaluate the use of vitamin K antagonists and new oral anticoagulants among non-valvular atrial fibrillation patients in Turkey- AFTER-2 study design

Ertas, Faruk; KAYA, HASAN; YILDIZ, ABDULKADİR; Davutoglu, Vedat; Kiris, Abdulkadir; Dinc, Lale; Kafes, Habibe; Avci, Anil; Calapkorur, Bekir; Ertas, Gokhan; Gul, Mehmet; KAHRAMAN AY, Nuray; Bulur, Serkan; Durukan, Mine; Eren, Murat; Ilhan, Ibrahim; KÜÇÜK, MURATHAN; ÖZPELİT, EBRU; Şimşek, Hakkı; Ucar, F.; Yildiz, Ahmet; Sahin, D.; Ayhan, Erkan; Caglayan, C.; GÜNGÖR, HASAN; Ozyurtlu, Ferhat; Sen, Nihat; Vatan, Bulent; Vatansever, Fahriye; Kobat, Mehmet; Temiz, Ahmet; TAYLAN, GÖKAY; Donmez, Ibrahim; Erkus, M.; Soylemez, Selami; Zengin, Halit; Gunduz, Mahmut; TUNÇEZ, ABDULLAH; KARAVELİOĞLU, YUSUF; Gokdeniz, Tayyar; KOZA, Yavuzer; Aktop, Ziyaeddin; Katlandur, Huseyin; Ozer, Pelin; YÜKSEL, MURAT; ACET, HALİT; ÇİL, HABİB; Alan, Sait; TOPRAK, NİZAMETTİN

doi:10.5543/tkda.2015.35984

An epidemiological study to evaluate the use of vitamin K antagonists and new oral anticoagulants among non-valvular atrial fibrillation patients in Turkey- AFTER-2 study design

Atıf İçin Kopyala

Ertas F., KAYA H., YILDIZ A., Davutoglu V., Kiris A., Dinc L., ...Daha Fazla

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.43, sa.2, ss.169-177, 2015 (ESCI)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 43 Sayı: 2
Basım Tarihi: 2015
Doi Numarası: 10.5543/tkda.2015.35984
Dergi Adı: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.169-177
Anahtar Kelimeler: Anticoagulant agent, atrial fibrillation/epidemiology, drug utilization, electrocardiography, international normalized ratio, warfarin
Akdeniz Üniversitesi Adresli: Evet

Özet

Objectives: Atrial fibrillation (AF) is one of the most common causes of preventable ischemic stroke and is related to increased cardiovascular morbidity and mortality. There is a lack of data in Turkey on the use of new oral anticoagulants (NOACs), and time in therapeutic INR range (TTR) in vitamin K antagonist users and AF management modality. In this multi-center trial, we aimed to analyze, follow and evaluate the epidemiological data in non-valvular AF patients.